MENU

Eureka projects

Lung cancer is a major killer worldwide, and no adequate treatment for this very common disease exists. The aim of the project is to develop a prophylactic vaccine against cmv, using proprietary antigens and production technologies.
Project ID: 
3548

Raising the productivity and competitiveness of European businesses through technology. Boosting national economies on the international market, and strengthening the basis for sustainable prosperity and employment.